99 related articles for article (PubMed ID: 30259932)
1. Troxerutin subdues hepatic tumorigenesis via disrupting the MDM2-p53 interaction.
Thomas NS; George K; Selvam AAA
Food Funct; 2018 Oct; 9(10):5336-5349. PubMed ID: 30259932
[TBL] [Abstract][Full Text] [Related]
2. The in vivo antineoplastic and therapeutic efficacy of troxerutin on rat preneoplastic liver: biochemical, histological and cellular aspects.
Thomas NS; George K; Arivalagan S; Mani V; Siddique AI; Namasivayam N
Eur J Nutr; 2017 Oct; 56(7):2353-2366. PubMed ID: 27488610
[TBL] [Abstract][Full Text] [Related]
3. Troxerutin with copper generates oxidative stress in cancer cells: Its possible chemotherapeutic mechanism against hepatocellular carcinoma.
Subastri A; Suyavaran A; Preedia Babu E; Nithyananthan S; Barathidasan R; Thirunavukkarasu C
J Cell Physiol; 2018 Mar; 233(3):1775-1790. PubMed ID: 28628229
[TBL] [Abstract][Full Text] [Related]
4. Formylchromone exhibits salubrious effects against nitrosodiethylamine mediated early hepatocellular carcinogenesis in rats.
Ilamathi M; Senthilkumar S; Prabu PC; Panchapakesan S; Sivaramakrishnan V
Chem Biol Interact; 2014 Aug; 219():175-83. PubMed ID: 24954034
[TBL] [Abstract][Full Text] [Related]
5. Anticancer mechanism of troxerutin via targeting Nrf2 and NF-κB signalling pathways in hepatocarcinoma cell line.
Thomas NS; George K; Selvam AAA
Toxicol In Vitro; 2019 Feb; 54():317-329. PubMed ID: 30389603
[TBL] [Abstract][Full Text] [Related]
6. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
7. Perillyl alcohol as a protective modulator against rat hepatocarcinogenesis via amelioration of oxidative damage and cell proliferation.
Sultana S; Nafees S; Khan AQ
Hum Exp Toxicol; 2013 Nov; 32(11):1179-92. PubMed ID: 23536516
[TBL] [Abstract][Full Text] [Related]
8. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
[TBL] [Abstract][Full Text] [Related]
9. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
10. MDM2-p53 pathway in hepatocellular carcinoma.
Meng X; Franklin DA; Dong J; Zhang Y
Cancer Res; 2014 Dec; 74(24):7161-7. PubMed ID: 25477334
[TBL] [Abstract][Full Text] [Related]
11. Dietary supplementation of silymarin is associated with decreased cell proliferation, increased apoptosis, and activation of detoxification system in hepatocellular carcinoma.
Gopalakrishnan R; Sundaram J; Sattu K; Pandi A; Thiruvengadam D
Mol Cell Biochem; 2013 May; 377(1-2):163-76. PubMed ID: 23397134
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent apoptosis contributes to di-(2-ethylhexyl) phthalate-induced hepatotoxicity.
Ha M; Wei L; Guan X; Li L; Liu C
Environ Pollut; 2016 Jan; 208(Pt B):416-25. PubMed ID: 26549752
[TBL] [Abstract][Full Text] [Related]
13. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
14. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
[TBL] [Abstract][Full Text] [Related]
15. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein.
Ortega JF; de Conti A; Tryndyak V; Furtado KS; Heidor R; Horst MA; Fernandes LH; Tavares PE; Pogribna M; Shpyleva S; Beland FA; Pogribny IP; Moreno FS
Oncotarget; 2016 Apr; 7(17):24339-47. PubMed ID: 27013579
[TBL] [Abstract][Full Text] [Related]
16. Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma.
Giovannini C; Minguzzi M; Baglioni M; Fornari F; Giannone F; Ravaioli M; Cescon M; Chieco P; Bolondi L; Gramantieri L
Oncotarget; 2014 Nov; 5(21):10607-20. PubMed ID: 25431954
[TBL] [Abstract][Full Text] [Related]
17. Thymoquinone inhibits cell proliferation through regulation of G1/S phase cell cycle transition in N-nitrosodiethylamine-induced experimental rat hepatocellular carcinoma.
Raghunandhakumar S; Paramasivam A; Senthilraja S; Naveenkumar C; Asokkumar S; Binuclara J; Jagan S; Anandakumar P; Devaki T
Toxicol Lett; 2013 Oct; 223(1):60-72. PubMed ID: 24012840
[TBL] [Abstract][Full Text] [Related]
18. MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.
Tovar C; Graves B; Packman K; Filipovic Z; Higgins B; Xia M; Tardell C; Garrido R; Lee E; Kolinsky K; To KH; Linn M; Podlaski F; Wovkulich P; Vu B; Vassilev LT
Cancer Res; 2013 Apr; 73(8):2587-97. PubMed ID: 23400593
[TBL] [Abstract][Full Text] [Related]
19. Loss of nuclear p53 protein in preneoplastic rat hepatocytes is accompanied by Mdm2 and Bcl-2 overexpression and by defective response to DNA damage in vivo.
Van Gijssel HE; Ohlson LC; Torndal UB; Mulder GJ; Eriksson LC; Porsch-Hällström I; Meerman JH
Hepatology; 2000 Oct; 32(4 Pt 1):701-10. PubMed ID: 11003613
[TBL] [Abstract][Full Text] [Related]
20. Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction.
Soares J; Pereira NA; Monteiro Â; Leão M; Bessa C; Dos Santos DJ; Raimundo L; Queiroz G; Bisio A; Inga A; Pereira C; Santos MM; Saraiva L
Eur J Pharm Sci; 2015 Jan; 66():138-47. PubMed ID: 25312347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
